View larger 
Last update : 17/05/2022
Surgical medical device
Ricrolin+® is a hypotonic ophthalmic solution based on 0.1% riboflavin, used for :
This product is no longer in stock
Availability date:
Ricrolin+ ®
Surgical medical device
Ricrolin+® is a hypotonic ophthalmic solution based on 0.1% riboflavin, used for :
Recipient :
* Required fields
or Cancel
Ricrolin®+ is indicated in combination with UV-A emitting surgical medical device for ophthalmologic use for corneal cross-linking (CXL) of eyes with primary corneal ectasia (progressive keratoconus, pellucid marginal degeneration) or iatrogenesis.
The treatment (UV-A + riboflavin) delays the progression of keratoconus.
The treatment prevents the need for corneal transplantation.
The treatment does not exclude the possibility of a keratoplasty at a later stage.
Composition:
Hypotonic Riboflavin 0.1%
Presentation:
1.5 mL sterile bottle
CE 0373 – Class IIb medical device
Manufacturer: FIDIA
French distributor: Horus Pharma
This medical device is a regulated health product which, under this regulation, bears the CE mark.
Read the instruction leaflet carefully before use.
MKT-DM-RIC-WEB-0001-112021
